Literature DB >> 10673391

Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity.

Y Miyamoto1, T Akaike, M S Alam, K Inoue, T Hamamoto, N Ikebe, J Yoshitake, T Okamoto, H Maeda.   

Abstract

alpha(1)-Protease inhibitor (alpha(1)PI), the most abundant serine protease inhibitor found in human plasma (at 30-60 microM), is a glycoprotein (53 kDa) having a single cysteine residue at position 232 (Cys(232)). We have found that Cys(232) of human alpha(1)PI was readily S-nitrosylated by nitric oxide (NO) without affecting inhibitory activity to trypsin or elastase. S-nitrosylated alpha(1)PI (S-NO-alpha(1)PI) not only retained inhibitory activity against these serine proteases, but also gained thiol protease inhibitory activity against a Streptococcus pyogenes protease; the parental alpha(1)PI did not have this activity. Furthermore, S-NO-alpha(1)PI exhibited bacteriostatic activity against Salmonella typhimurium at concentrations of 0.1-10 microM, which were 20- to 3000-fold stronger than those of the other NO-generating compounds or S-nitroso compounds such as S-nitrosoalbumin and S-nitrosoglutathione. NO appears to be transferred into the bacterial cells from S-NO-alpha(1)PI via transnitrosylation, as evidenced by electron spin resonance spectroscopy with an NO spin trap. Thus, we conclude that S-NO-alpha(1)PI may be generated from the reaction between alpha(1)PI and NO under inflammatory conditions, in which production of both is known to increase. As a result, new functions, i.e., antibacterial and thiol protease inhibitory activities of alpha(1)PI, were generated. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673391     DOI: 10.1006/bbrc.1999.2046

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

Review 3.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

4.  Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities.

Authors:  Mohammad Samiul Alam; Takaaki Akaike; Shinichiro Okamoto; Tatsuo Kubota; Jun Yoshitake; Tomohiro Sawa; Yoichi Miyamoto; Fumio Tamura; Hiroshi Maeda
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Alpha-1 Antitrypsin Therapy for Autoimmune Disorders.

Authors:  Sihong Song
Journal:  Chronic Obstr Pulm Dis       Date:  2018-10-05

6.  Anti-inflammaging effects of human alpha-1 antitrypsin.

Authors:  Ye Yuan; Benedetto DiCiaccio; Ying Li; Ahmed S Elshikha; Denis Titov; Brian Brenner; Lee Seifer; Hope Pan; Nurdina Karic; Mohammad A Akbar; Yuanqing Lu; Sihong Song; Lei Zhou
Journal:  Aging Cell       Date:  2017-10-17       Impact factor: 9.304

7.  S-Nitrosylation of α1-Antitrypsin Triggers Macrophages Toward Inflammatory Phenotype and Enhances Intra-Cellular Bacteria Elimination.

Authors:  Ziv Kaner; Rotem Engelman; Ronen Schuster; Peleg Rider; David Greenberg; Yossef Av-Gay; Moran Benhar; Eli C Lewis
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

Review 8.  Role of free radicals in viral pathogenesis and mutation.

Authors:  T Akaike
Journal:  Rev Med Virol       Date:  2001 Mar-Apr       Impact factor: 6.989

Review 9.  Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein.

Authors:  Urszula Lechowicz; Stefan Rudzinski; Aleksandra Jezela-Stanek; Sabina Janciauskiene; Joanna Chorostowska-Wynimko
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

Review 10.  Potential Nutrients from Natural and Synthetic Sources Targeting Inflammaging-A Review of Literature, Clinical Data and Patents.

Authors:  Sushruta Koppula; Mahbuba Akther; Md Ezazul Haque; Spandana Rajendra Kopalli
Journal:  Nutrients       Date:  2021-11-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.